184 related articles for article (PubMed ID: 27592800)
1. TIGIT and Helios Are Highly Expressed on CD4
Jariwala N; Benoit B; Kossenkov AV; Oetjen LK; Whelan TM; Cornejo CM; Takeshita J; Kim BS; Showe LC; Wysocka M; Rook AH
J Invest Dermatol; 2017 Jan; 137(1):257-260. PubMed ID: 27592800
[No Abstract] [Full Text] [Related]
2. Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sézary syndrome using T-cell receptor Vbeta chain antibodies and its application in blood staging.
Feng B; Jorgensen JL; Jones D; Chen SS; Hu Y; Medeiros LJ; Wang SA
Mod Pathol; 2010 Feb; 23(2):284-95. PubMed ID: 19935642
[TBL] [Abstract][Full Text] [Related]
3. Serum Soluble CD48 Levels as a Prognostic Marker in Mycosis Fungoides and Sézary Syndrome.
Oka T; Miyagaki T; Takahashi N; Nakajima R; Kamijo H; Suga H; Asano Y; Sugaya M; Sato S
J Invest Dermatol; 2018 Oct; 138(10):2286-2288. PubMed ID: 29605670
[No Abstract] [Full Text] [Related]
4. Serum-soluble herpes virus entry mediator levels reflect disease severity and Th2 environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Acta Derm Venereol; 2013 Jul; 93(4):465-7. PubMed ID: 23306973
[No Abstract] [Full Text] [Related]
5. Mycosis fungoides. Diagnosis and pathogenesis.
Barcos M
Am J Clin Pathol; 1993 Apr; 99(4):452-8. PubMed ID: 8475912
[No Abstract] [Full Text] [Related]
6. Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome.
Shono Y; Suga H; Kamijo H; Fujii H; Oka T; Miyagaki T; Shishido-Takahashi N; Sugaya M; Sato S
Acta Derm Venereol; 2019 Jul; 99(9):809-812. PubMed ID: 31045236
[TBL] [Abstract][Full Text] [Related]
7. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
8. [Epidermotropic T lymphomas].
Sigal-Nahum M; Brousse N; Belaïch S
Rev Prat; 1987 May; 37(25):1423-31. PubMed ID: 3495856
[No Abstract] [Full Text] [Related]
9. Ultrastructural morphometry in the diagnosis of mycosis fungoides and Sézary's syndrome.
Payne CM
Clin Dermatol; 1991; 9(2):187-203. PubMed ID: 1747854
[No Abstract] [Full Text] [Related]
10. Increased 2',5'-oligoadenylate synthetase activity in blood mononuclear leukocytes from patients with advanced cutaneous T-cell lymphoma.
Vonderheid EC; Suhadolnik RJ; Sobel EL; Flick MB; Mosca JD
Clin Immunol Immunopathol; 1984 Apr; 31(1):138-50. PubMed ID: 6199147
[TBL] [Abstract][Full Text] [Related]
11. Report of the Committee on Pathology of Cutaneous T Cell Lymphomas.
Clendenning WE; Rappaport HW
Cancer Treat Rep; 1979 Apr; 63(4):719-24. PubMed ID: 376141
[No Abstract] [Full Text] [Related]
12. Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome.
Meyerson HJ; Awadallah A; Pavlidakey P; Cooper K; Honda K; Miedler J
Mod Pathol; 2013 Jan; 26(1):32-43. PubMed ID: 22918164
[TBL] [Abstract][Full Text] [Related]
13. CD164 identifies CD4
Benoit BM; Jariwala N; O'Connor G; Oetjen LK; Whelan TM; Werth A; Troxel AB; Sicard H; Zhu L; Miller C; Takeshita J; McVicar DW; Kim BS; Rook AH; Wysocka M
Arch Dermatol Res; 2017 Jan; 309(1):11-19. PubMed ID: 27766406
[TBL] [Abstract][Full Text] [Related]
14. Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma.
Ohmatsu H; Sugaya M; Suga H; Morimura S; Miyagaki T; Kai H; Kagami S; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Acta Derm Venereol; 2012 May; 92(3):282-3. PubMed ID: 22456907
[No Abstract] [Full Text] [Related]
15. Dual CD4/CD8-positive Ichthyosiform Mycosis Fungoides with Lymph Node, Peripheral Blood and Cardiac Involvement: A Case Report.
Kaku Y; Otsuka A; Tanizaki H; Shibuya R; Endo Y; Nonomura Y; Hirata M; Fujimoto M; Ohmori K; Sakurai T; Kabashima K
Acta Derm Venereol; 2016 May; 96(4):564-6. PubMed ID: 26633168
[No Abstract] [Full Text] [Related]
16. New aspects of the clinicopathological features and treatment of mycosis fungoides and Sézary syndrome.
Furue M; Kadono T
J Dermatol; 2015 Oct; 42(10):941-4. PubMed ID: 26432429
[TBL] [Abstract][Full Text] [Related]
17. Is there a role for epigenetic factors in the pathogenesis of epidermotropic cutaneous T-cell lymphomas (mycosis fungoides and Sézary syndrome)?
Bachelez H
Hematol J; 2001; 2(4):286-9. PubMed ID: 11920262
[No Abstract] [Full Text] [Related]
18. Mycosis fungoides.
Gaeke ME; Variakojis D; Sweet DL
Curr Probl Cancer; 1981 Sep; 6(3):1-39. PubMed ID: 7285618
[No Abstract] [Full Text] [Related]
19. Immunophenotyping on simultaneously occurring plaques and tumours in mycosis fungoides and Sézary syndrome.
Preesman AH; Toonstra J; van der Putte SC; van Vloten WA
Br J Dermatol; 1993 Dec; 129(6):660-6. PubMed ID: 8286248
[TBL] [Abstract][Full Text] [Related]
20. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
